ABA.-L. Bedat-Millet
A.-L. Bedat-Millet
*This is an algorithmically generated author record based on publicly available information.
Research Subjects
A.-L. Bedat-Millet has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
A. Canal
1 shared publicationA. Didier-Laurent
Department of Neurology, Le Havre Hospital, Le Havre, France
1 shared publicationA. Dutry
1 shared publicationA. Nadaj-Pakleza
1 shared publicationAlain Furby
Centre de référence des maladies neuromusculaires rares Rhône-Alpes, Hôpital Nord, CHU de Saint-Etienne, Saint-Etienne, France
1 shared publication- Alexis Demas
ARGOS (Arts, Research and Gestures Observed Scientifically) Neurosciences and Arts, Paris, France
1 shared publication
Latest Publications
- Open Access
- 25 July 2025
- Published by Elsevier in Revue Neurologique
- Vol. 181 (8) , 742-747
Neurological damage from recreational nitrous oxide use: Two distinct electroclinical profiles in a retrospective cohort
- 25 July 2025
- Published by Elsevier in Revue Neurologique
- Vol. 181 (8) , 742-747
Open AccessNeurological damage from recreational nitrous oxide use: Two distinct electroclinical profiles in a retrospective cohort
- 3 February 2024
- Published by Elsevier in Revue Neurologique
- Vol. 180 (6) , 564-565
Neurodystrophic hand dermatitis – Sannino-Barduagni syndrome
- 3 February 2024
- Published by Elsevier in Revue Neurologique
- Vol. 180 (6) , 564-565
Neurodystrophic hand dermatitis – Sannino-Barduagni syndrome
- 1 September 2017
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 122 (1-2) , 80-85
Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease
- 1 September 2017
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 122 (1-2) , 80-85
Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease